ACCENDRA HEALTH INC/VA/
ACHCIK 0000075252
Revenue (TTM)
$2.68B
+3.1% YoY
Q1 Mar 2026
Net Income (TTM)
−$1.05B
−203.5% YoY
Q1 Mar 2026
EPS Diluted (TTM)
−$13.64
−202.5% YoY
Q1 Mar 2026
Gross Margin
80.8%
Q1 Mar 2026
Operating Margin
0.9%
Q1 Mar 2026
Net Margin
-39.2%
Q1 Mar 2026
Free Cash Flow (TTM)
−$29.52M
Q1 Mar 2026
Cash
$336.88M
Q1 Mar 2026
Total Debt
$1.57B
Q1 Mar 2026
Shares Outstanding
76.58M sh
Q1 Mar 2026